Friday broker round-up

(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.

Tyman: Liberum reiterates buy with a target price of 300p.

Experian: Deutsche Bank upgrades to hold with a target price of 2,200p.

Burberry: Deutsche Bank reiterates hold with a target price of 2,010p.

AstraZeneca: Liberum Capital reiterates buy with a target price of 8,250p.

GlaxoSmithKline: Jefferies reiterates buy with a target price of 1,850p.

Workspace: Berenberg downgrades to sell with a target price of 950p.

Berkeley Group: Goldman Sachs downgrades to sell with a target price of 3,860p.

Burberry: Credit Suisse reiterates outperform with a target price of 2,700p.

Genus: Jefferies initiates hold with a target price of 3,272p.

Wetherspoon: Barclays reiterates overweight with a target price of 1,690p.

RHI Magnesita: Barclays reiterates overweight with a target price of 4,400p.

Ted Baker: RBC Capital Markets reiterates sector performer with a target price of 440p Burberry Wetherspoon (J.D) Astrazeneca Berkeley Group Workspace Genus Experian Glaxosmithkline Whitbread RHI Magnesita